Glucagon-like peptide-1 (GLP-1) agonists are injectable weight loss drugs that help people feel fuller and eat less food, leading to weight loss
Importantly, it does not typically drive insulin release under low-glucose conditions, reducing hypoglycemia risk in research settings
Combined with its exceptional protein density, clinical blood sugar evidence, and broad nutritional profile, its the single most effective food you can add to a GLP-1 support strategy
See the details in our article about supplements for weight and appetite control
Chris Serres: Thank you so much for doing it
Animal model studies have suggested that GLP-1RAs may cause pancreatitis and exocrine dysplasia, but in the large RCTs and a meta-analysis, GLP-1RAs did not increase the risk of pancreatitis or pancreatic cancer [82,83]